Safety of Immune Checkpoint Inhibitors With Nephrectomy in mRCC

A pilot study evaluated  cytoreductive surgery combined with immune checkpoint therapy in patients with metastatic renal cell carcinoma.

Source: CancerNetwork - June 4, 2019 Category: Cancer & Oncology Authors: Jim Kling Source Type: news